Baoy, Ziah D.
HRN: 24-24-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/14/2023
12/21/2023
PO
5ml
Q8hours
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes